The Food and Drug Administration (FDA) launched a pilot program in October, allowing certain promising drugs and treatments the chance to get much faster approval. The “National Priority Vouchers” ...
The FDA plans to introduce a faster approval process for custom gene-editing therapies, allowing combined trials for patients with related rare genetic disorders, Bloomberg’s Gerry Smith reports. This ...
The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback